Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 11
Submit an article Journal homepage
153
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma

David A. Russler-Germaina Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1009-2247View further author information
ORCID Icon,
Brendan R. Calhounb Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United StatesView further author information
,
Ningying Wuc Public Health Sciences Division, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United StatesView further author information
,
Marcus P. Watkinsa Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesORCID Iconhttps://orcid.org/0000-0002-1224-3478View further author information
ORCID Icon,
Barry A. Siegelb Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States;d Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United StatesORCID Iconhttps://orcid.org/0000-0001-6246-5792View further author information
ORCID Icon,
Nancy L. Bartletta Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States;d Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United StatesORCID Iconhttps://orcid.org/0000-0001-8470-394XView further author information
ORCID Icon &
Joyce C. Mhlangab Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United StatesORCID Iconhttps://orcid.org/0000-0002-6136-265XView further author information
ORCID Icon show all
Pages 1870-1874 | Received 03 Apr 2023, Accepted 10 Jul 2023, Published online: 25 Jul 2023

References

  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3068. doi:10.1200/JCO.2013.54.8800
  • Barrington SF, Trotman J. The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. Lancet Haematol. 2021;8(1):e80–e93. doi:10.1016/S2352-3026(20)30365-3
  • Johnson P, Federico M, Kirkwood A, et al. Adapted treatment guided by interim PET-CT scan in advanced hodgkin’s lymphoma. N Engl J Med. 2016;374(25):2419–2429. doi:10.1056/NEJMoa1510093
  • André MPE, Girinsky T, Federico M, et al. Early positron emission tomography response–adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 2017;35(16):1786–1794. doi:10.1200/JCO.2016.68.6394
  • Dührsen U, Müller S, Hertenstein B, et al. Positron emission tomography–guided therapy of aggressive non-Hodgkin lymphomas (PETAL): a multicenter, randomized phase III trial. J Clin Oncol. 2018;36(20):2024–2034. doi:10.1200/JCO.2017.76.8093
  • Persky DO, Li H, Stephens DM, et al. Positron emission tomography–directed therapy for patients with limited-stage diffuse large B-cell lymphoma: results of intergroup national clinical trials network study S1001. J Clin Oncol. 2020;38(26):3003–3011. doi:10.1200/JCO.20.00999
  • Bailly C, Carlier T, Berriolo-Riedinger A, et al. Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET project. Haematologica. 2020;105(1):e33–e36. doi:10.3324/haematol.2019.223016
  • Bailly C, Carlier T, Touzeau C, et al. Interest of FDG-PET in the management of mantle cell lymphoma. Front Med. 2019;6:70. doi:10.3389/fmed.2019.00070
  • Albano D, Treglia G, Gazzilli M, et al. 18F-FDG PET or PET/CT in mantle cell lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20(7):422–430. doi:10.1016/j.clml.2020.01.018
  • Itti E, Meignan M, Berriolo-Riedinger A, et al. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. Eur J Nucl Med Mol Imaging. 2013;40(9):1312–1320. doi:10.1007/s00259-013-2435-6
  • Schöder H, Polley M-YC, Knopp MV, et al. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 clinical trial. Blood. 2020;135(25):2224–2234. doi:10.1182/blood.2019003277
  • Allioux F, Gandhi D, Vilque J-P, et al. End-of-treatment 18 F-FDG PET/CT in diffuse large B cell ­lymphoma patients: ΔSUV outperforms Deauville score. Leukemia Lymphoma. 2021;62(12):2890–2898. doi: 10.1080/10428194.2021.1948028. Epub 2021 Jul 5.
  • Eertink JJ, Burggraaff CN, Heymans MW, et al. Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood Adv. 2021;5(9):2375–2384. doi:10.1182/bloodadvances.2021004467
  • Mehta-Shah N, Ito K, Bantilan K, et al. Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma. Blood Adv. 2019;3(2):187–197. doi:10.1182/bloodadvances.2018024075
  • Gouill SL, Thieblemont C, Oberic L, et al. Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma. N Engl J Med. 2017;377(13):1250–1260. doi:10.1056/NEJMoa1701769

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.